Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE).
Saved in:
| Title: | Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE). |
|---|---|
| Authors: | Wiesner L; a Novartis Pharma AG, Postfach , Basel , Switzerland., Prause M; a Novartis Pharma AG, Postfach , Basel , Switzerland., Lovsin Barle E; a Novartis Pharma AG, Postfach , Basel , Switzerland. |
| Source: | Pharmaceutical development and technology [Pharm Dev Technol] 2018 Mar; Vol. 23 (3), pp. 261-264. Date of Electronic Publication: 2017 Jun 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9610932 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-9867 (Electronic) Linking ISSN: 10837450 NLM ISO Abbreviation: Pharm Dev Technol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
